BioCentury @BioCentury
The leading voice for decision-makers throughout the global biopharma ecosystem. Follow us on LinkedIn for exclusive insights & analysis: https://t.co/V33Z1gfUfZ biocentury.com Redwood City, Calif. Joined December 2010-
Tweets37K
-
Followers16K
-
Following2K
-
Likes4K
EMA’s CHMP recommends approval of Takeda’s VEGF therapy, Idorsia’s hypertension drug. April opinions also include earlier-line use of J&J’s Rybrevant and BMS’s Opdivo. @EMA_News buff.ly/4aWKiOz
Federal judge rules against $BMY, $JNJ in IRA case, adding to industry's string of defeats. buff.ly/4bhrh9m
.@US_FDA's Peter Marks' plans to energize #genetherapy. Plus: AI newco Xaira & Ono's $2.4B takeout of @Deciphera — a BioCentury podcast buff.ly/3UEadom
BioCentury's latest roundup of management moves: New CEOs at Evox and George Medicines. Plus: Stoke hires Thomas Leggett as CFO, and updates from TScan, Rinri, Tevogen and more $STOK $TCRX $TVGN buff.ly/4bfuSES
The $XBI is once again at the whim of U.S. interest rates, with the ETF falling since mid-March while the $TNX has climbed 20% YTD buff.ly/3Umajj7
Seeking to build its presence in the U.S., Ono is spending $2.4B to buy @Deciphera in a deal giving it one marketed oncology drug and another therapy on the brink of a regulatory submission buff.ly/3WnlgDE
It's officially TWO WEEKS until we open the doors in San Sebastian for #BioEquityEurope 🙌🎉 LIMITED SEATS REMAIN Register now to secure your spot for the 24th Bio€quity Europe – before it sells out bit.ly/47HbaR2 #biotech #biopharma #venturecapital #investors #VCs
Public equity report: @CidaraThera resets with $240M PIPE; @centessa raises $100M in first follow-on since 2021 IPO buff.ly/4ddlS4N
FDA's supplemental approvals in March included accelerated approval conversions for Elahere and Rybrevant, and half a dozen label expansions into earlier treatment lines or new indications. buff.ly/3UglGsT
BioCentury's roundup of translational innovations includes tumor T cell restriction mechanisms, a CRISPR system for programmable RNA excision, and more buff.ly/3wchYIM
Keytruda is still growing, while Opdivo has long since plateaued. Their sales differential was over $4 billion last quarter. buff.ly/3wdgU7r
Visgenx is taking retinal gene therapy beyond rare diseases, starting with a dry AMD program encoding ELOVL2, an enzyme involved in the very long chain fatty acid synthesis pathway. An Emerging Company Profile by BioCentury's @DanielleGolovin buff.ly/4ddvixf
Peter Marks, director of @US_FDA's CBER, plans to lean in to accelerated approval for gene therapy, believes gene editing could be game changer. buff.ly/3xSg2pt
Venture report: While the $1B commitment to AI company Xaira by VCs including Arch and Foresite drew the most attention this week, venture dollars also went to Rubedo, Flindr, Endeavor, SynOx and others buff.ly/4daTrV3
BioCentury's latest roundup of management moves: Randy Teel named CBO at Arvinas. Plus: Meenu Chhabra Karson becomes chair at Harness, and an update from Ontada $ARVN buff.ly/3Ui4WRR
Building bridges between biomedical stakeholders: guiding principle for new NCI Director W. Kimryn Rathmell as she takes the reins at @theNCI. A Q&A with BioCentury's Emily Arner buff.ly/4b9iOow
First-in-human compounds at #AACR24 highlight emerging innate immune targets: ALPK1 and ENPP1 buff.ly/4dpAi1Y
#BioEquityEurope is known for introducing new companies to VCs and BD&L leaders, and we're happy to announce that half of the presenting companies this year are new to the Bio€quity stage! Click here for the full agenda and presenting companies schedule: loom.ly/F006sMo
The IRA's boost to generics: By decreasing Medicare’s contribution to the cost of branded Part D drugs, the Act can make generic drugs cheaper for plans — even after manufacturer rebates. @CMSGov buff.ly/3JwdUpM
BioCentury's latest roundup of management moves: Smart to lead Actym as CEO. Plus: Ramanayake joins CureVac and updates from Oruka, Madrigal and AusBiotech $CVAC $MDGL buff.ly/3Wf7Mtz
Bruce Booth @LifeSciVC
50K Followers 731 Following Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
Daphne Zohar @daphnezohar
22K Followers 886 Following Founder & CEO of @SeaportTX. Founding CEO & now Senior Advisor @PureTechH. I share biotech news & commentary. Co founder/host @BiotechCH. Board @IamBiotech
Michael Gilman @michael_gilman
24K Followers 785 Following Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player, #immigrant. CEO @ArrakisTx. Just @gilman on...
Andrew Pannu @andrewpannu
10K Followers 274 Following daily dose of biotech & healthcare commentary • founder • building software for the bioeconomy (we’re hiring software engineers!)
John Maraganore 🇺�.. @JMaraganore
14K Followers 412 Following Founding CEO of @Alnylam. Pioneered RNAi therapeutics as a whole new class of medicines for patients. Now bioentrepreneur-at-large. Opinions are my own.
Jing Liang 🇺🇦 @AppleHelix
8K Followers 4K Following Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by @VPrasadMDMPH. https://t.co/zMzJBoov2V
Jeb Keiper @JebKeiper
4K Followers 418 Following CEO @NimbusTx. A guy (he/him) helping teams discover and develop new medicines for patients. Any tweets are solely my own personal views.
Jay Bradner, M.D. @jaybradner
22K Followers 938 Following Physician-scientist making medicines with friends, memories with family. EVP R&D and CSO at Amgen
Professor Oak @Prof_Oak_
8K Followers 649 Following Biopharma Musings | Genetic Medicine & Rare Disease | Buyside Turned Operator | Not Investment Advice | DYODD
David Grainger @sciencescanner
14K Followers 797 Following Biotech entrepreneur & Partner @Medicxi Advocate of virtual, asset-centric R&D. All opinions my own
Sara Nayeem @SaraNayeem
11K Followers 2K Following Invest in emerging biopharma co's as EVP, Investments at Enavate Sciences. Prior NEA and Avoro Ventures. I post advice for biopharma exec's and emerging VCs.
Madeleine Armstrong @ByMadeleineA
7K Followers 1K Following Senior reporter at @ApexOnco; cat lover; Croydon Harrier
Ingo Hartung @HartungIngo
14K Followers 780 Following MedChem @Merckgroup; drug discovery nerd in oncology, immunology & targeted protein degradation, soccer, politics or tapas can get into the way; my own views
Andrew Dunn @AndrewE_Dunn
10K Followers 2K Following Senior biopharma correspondent at @endpts | Previously @BusinessInsider @BioPharmaDive | Tips? DM or 978-577-5798 (Signal/text) [email protected]
STAT @statnews
165K Followers 5K Following Reporting from the frontiers of health & medicine. Sign up for any of our 10 free newsletters here: https://t.co/CBx3GZBv31
FierceBiotech @FierceBiotech
101K Followers 649 Following The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
Sek Kathiresan MD @skathire
30K Followers 989 Following CEO @VerveTx $VERV; Imagine if a one-time treatment led to permanent lowering of LDL cholesterol: that’s what we are developing to treat heart attack
Nature Reviews Drug D.. @NatRevDrugDisc
38K Followers 479 Following Editorial team of Nature Reviews Drug Discovery.
Big Pharma Globalist @BigPharmaNeoLib
17 Followers 61 Following
Simon L @SnupSnus
2K Followers 1K Following Interested in the HealthCare Biotech/Pharma industry! #aging too. Occasional math(s) . Not investment advice etc etc
Monaco @monaco_biotech
3K Followers 1K Following #biotech investor since 1998. Also tech investor. I trade longterm, swing, day. My tweets are not investment advice.
Palabra Médica @palabramedica
44 Followers 105 Following Perspectivas de salud, industria y política sanitaria
Biotech Shoutouts @BiotechSho99376
5 Followers 30 Following Here to call out dumb things in biotech - of which there are so very many. Views are my own. If you trade off the back of them that's your fault
Kim MacPherson @KimMacSF
196 Followers 235 Following Health innovation educator/mentor @Berkeley SPH & Haas, SFUSD & UO parent, Board Chair Saint Francis Memorial Hospital, Peloton enthusiast - opinions are my own
BioTalk Unzipped @BiotalkUnzipped
1 Followers 21 Following Unzipping the Stories Behind Medical Progress by sharing the latest and greatest advances in biopharmaceuticals and medical technologies in a fun, entertaining,
KOL Pulse AI @KolPulseAI
426 Followers 3K Following KOL Pulse AI is a Healthcare Intelligence Application focused on the Social Conversations and Digital Signature of Key Opinion Leaders in Medicine.
DeirdreSpender @y1U94bZGIleROP
2 Followers 117 Following
Chen Dayuan @Chen_DNg
37 Followers 190 Following
TrendSetter @NikolaG41538546
109 Followers 842 Following
Alex Schriver @AlexSchriver
8K Followers 3K Following Husband, Father, Son | Senior Vice President of Public Affairs @PhRMA | @Nationals & @PGATour Fan
Health123 @mulford_hu41099
3 Followers 32 Following
Curtis Tyree @curtremarks
69 Followers 175 Following Works in pharmaceutical discovery and development. Will ignore photos/videos that lack dates and places. Trying to be kind.
Sabah Öney @sabahoney
1K Followers 1K Following CEO at stealth biotech 🔬PhD in genetics 🧬Duke 🏀 Warriors 🏀 Redbull🏎 from Cyprus 🇨🇾 equally at home in the US 🇺🇸 certified sommelier, in training 🍷
Pablo Ramos @pramosferrer
189 Followers 448 Following ChemE PhD | Consultant | Biotech | Ibiza native in the U.S. | (Bio)Techno-optimist | Questioning everything, always
Harpreet Singh, MD @harpreet_md
2K Followers 806 Following Director, Division of Oncology 2 @FDAOncology Former NCI Fellow, USC Trojan ✌🏽🩺
Exxel Pharma @ExxelPharm
2 Followers 40 Following We are developing novel therapeutics for the treatment of neuronal hypersensitivity disorders. #ChronicCough #HyperactiveBladder #NeuropathicPain #Migraine
Long @longbios
12 Followers 136 Following former buy / sell side currently biotech exec + bio investor
feverfew @feifeverfew
43 Followers 245 Following
Mollie Godbout @mollie_godbout
22 Followers 110 Following Healthcare Media Relations at LifeSci Communications; Villanova ‘19
Jessica Simpkin @jsimpkinn
3 Followers 54 Following
Sarah Y Neshat @sarahyneshat
328 Followers 850 Following @JHUBME PhD Candidate @jgreengroup // @dolofflab ◦ Biochemist 🧪 // Biomedical Engineer 🧬◦ Ethiopian 🇪🇹 // Yemeni 🇾🇪
Antho @superloulout
2 Followers 565 Following
Weimin Valenti @ValentiWei64845
0 Followers 3 Following
Josh Woh @woh_josh
0 Followers 51 Following
Ollie Curtis @healthonomix
242 Followers 161 Following Make Digital Visible 🧬 Founder @Healthonomix • Raising consumer Health-IQ by providing actionable insights into the latest Digital Health trends • Views = Mine
G.C. Xie @xieguoch
34 Followers 301 Following
Dr Gordon Smith Baxte.. @baxtergo
5 Followers 89 Following Molecular Pharmacologist, Technology Entrepreneur, Muscian & Photographer.
Allena @Allena33126267
491 Followers 724 Following
Dr. Paul De Santis, P.. @DrPaulyDeSantis
6K Followers 4K Following Opinions are my own: Former GLG Council Member (Oncology, IO, CAR T)
Anand C. Patel, MD MS @anandcpatelmdms
1K Followers 3K Following Pediatric pulmonologist and bioinformaticist, now in drug development. He/him. https://t.co/61YX7H46Pc @PioneeringMeds https://t.co/LqrSTRsx0C too
Pat Sharp @PatSharpChem
541 Followers 1K Following Scientific co-founder Gate Bio | curing disease | prev: @Merck medicinal chemistry
Laila S @LailaS2002
0 Followers 8 Following
Amy @amymariap
35 Followers 260 Following
Nick Picca @NickPicca
87 Followers 453 Following Healthcare, Technology, and Services at RA Capital. Tweets and opinions are my own.
Henk Jan Out @HenkJanOut
3K Followers 626 Following MD PhD | Former pharma executive | Author 'Leve het Geneesmiddel!' | Consultant | Podcast Host https://t.co/IvSsXbemcg | Piano | Church Organ
Daniel Bode @Bode_Dan
74 Followers 328 Following Senior BD Associate @STRMbio | PhD in Stem Cell Biology & Medicine from @Cambridge_Uni | Gene Therapy focus
James alsterlind @jeyemmwhy
6 Followers 106 Following
ClarityCapital @ClarityBioCap
11 Followers 76 Following This body holding me reminds me of my own mortality. Long-only Biotech investor. Tweets are my own opinion, which can change. For information purposes only.
Chuck Silberstein @Chucksilb
2 Followers 115 Following
Brad Loncar @bradloncar
69K Followers 365 Following #Biotech, Founder of @BiotechTVHQ, KC native, @univmiami hurricane.🧬🙌
Adam Feuerstein ✡�.. @adamfeuerstein
114K Followers 750 Following Reporter @statnews. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously.
Bruce Booth @LifeSciVC
50K Followers 731 Following Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
Daphne Zohar @daphnezohar
22K Followers 886 Following Founder & CEO of @SeaportTX. Founding CEO & now Senior Advisor @PureTechH. I share biotech news & commentary. Co founder/host @BiotechCH. Board @IamBiotech
Bertrand Delsuc @BertrandBio
16K Followers 253 Following Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design) & a bit of Bio :)
Michael Gilman @michael_gilman
24K Followers 785 Following Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player, #immigrant. CEO @ArrakisTx. Just @gilman on...
Matthew Herper @matthewherper
111K Followers 3K Following Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Mastodon: @[email protected]
David R. Liu @davidrliu
64K Followers 59 Following Professor at Harvard, Broad Institute, & HHMI. Our lab integrates chemistry & evolution to illuminate biology & enable new therapeutics. IG/Threads: @davidrliu1
Peter Kolchinsky @PeterKolchinsky
66K Followers 181 Following Managing Partner, RA Capital Management. We build & invest in biotech companies. Scientist. Author, The Great American Drug Deal. https://t.co/ARVLrrTQU4
Luke Timmerman @ldtimmerman
35K Followers 231 Following Biotech Journalist. Founder @TimmermanReport. Mountaineer. Volunteer. @LS_Cares @DamonRunyon
Biotech Hangout @BiotechCH
12K Followers 451 Following Weekly discussion of biotech news w/ @daphnezohar @bradloncar @timopler @LifeSciVC, @cngarabedian, top analysts & a community of biotech insiders
Endpoints News @endpts
29K Followers 68 Following The biopharma world is here. Get the industry’s most comprehensive daily news reports at https://t.co/qpcDlbaOSx
John Maraganore 🇺�.. @JMaraganore
14K Followers 412 Following Founding CEO of @Alnylam. Pioneered RNAi therapeutics as a whole new class of medicines for patients. Now bioentrepreneur-at-large. Opinions are my own.
Jing Liang 🇺🇦 @AppleHelix
8K Followers 4K Following Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by @VPrasadMDMPH. https://t.co/zMzJBoov2V
Jeb Keiper @JebKeiper
4K Followers 418 Following CEO @NimbusTx. A guy (he/him) helping teams discover and develop new medicines for patients. Any tweets are solely my own personal views.
Jay Bradner, M.D. @jaybradner
22K Followers 938 Following Physician-scientist making medicines with friends, memories with family. EVP R&D and CSO at Amgen
John Carroll @JohnCendpts
70K Followers 94 Following Working journalist for 46 years, invented FierceBiotech, founded Endpoints News now majority-@FT owned. 201,000 subscribers. These are personal opinions.
Frank S. David @Frank_S_David
7K Followers 559 Following Biotech advisor @Pharmagellan. Professor of the Practice of Biotech @tufts_biology.
HealthTech For Care @Healthtech4Care
155 Followers 54 Following The HealthTech For Care endowment fund aims to support and promote access to healthcare for all.
BioXchange @BosBioXchange
534 Followers 912 Following Boston's premier biotech networking group hosted by some of the industry's most connected. Events rotate between Cambridge and Waltham.
Larry Huynh @larryhuynh
113K Followers 1K Following Democratic messaging strategist working with @TrilogyInt to defeat Republican idiocy. Don't follow me if you hate Asian gay snarky Dads who have no time for BS.
David Mandel @DavidHMandel
26K Followers 60 Following Veep, Curb, Seinfeld, SNL, Eurotrip & Clerks Cartoon. Collector: props & comic art. Host: The Stuff Dreams Are Made Of Podcast
Birmingham 81 @Birmingham_81
48K Followers 2K Following Music, architecture, photography, design etc. Sharing my concert photos taken in Birmingham in 81/82 (hence the name). Plus other stuff I've hoarded
CALL TO ACTIVISM @CalltoActivism
1.1M Followers 2K Following Owned and operated by Attorney Joe Gallina. Newsletter: https://t.co/CalGHt2ALQ
BioWin - The Health C.. @BioWin_asbl
2K Followers 984 Following BioWin, your gateway to biotech and medtech excellence
Third Harmonic Bio @3rdHarmonicBio
111 Followers 47 Following A clinical-stage company developing a novel oral approach to the treatment of severe allergy and inflammation.
No Patient Left Behin.. @NPLB_org
1K Followers 334 Following We're a non-profit dedicated to making medications affordable for everyone in America. Follow us here for advice on how to deal with health insurance companies.
Angie You @Angiejyou
626 Followers 458 Following STEMinist, Biotech CEO Sister, mountain girl and obsessed fur baby mamma #luvrescuedogs
Balderton Capital @balderton
46K Followers 2K Following Backing Europe's best founders from Seed to IPO. Get in touch: https://t.co/c6PKxEeKtA
James Wise @jamespaulwise
14K Followers 3K Following Partner @Balderton. Investing in AI, health and sustainability. UK Industrial Development Board. Author of Start-Up Century.
American Cancer Socie.. @AmericanCancer
1.1M Followers 165K Following Our vision is to end cancer as we know it, for everyone. Learn more at https://t.co/sAXpTAj08D or call us 24/7 at 1-800-227-2345. Proudly a top rated organization.
BowTiedBiotech 🧪�.. @BowTiedBiotech
12K Followers 7K Following Tri-Weekly Biotech Updates: Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends | Current: Biotech VC
David Fajgenbaum, MD @DavidFajgenbaum
11K Followers 3K Following @Penn physician-scientist-patient who 'cured thyself' | Advancing @CureCastleman + @EveryCure | National Bestseller #ChasingMyCure https://t.co/26OS13etrF
Kun Zhang @ Pharmcube @KunZhan76598280
44 Followers 59 Following A leading medicine intelligence supplier, covering the whole lifecycle from early development to commerical. Please send email to: [email protected].
Metagenomi @metagenomi
710 Followers 76 Following Using natural microbial communities to discover and develop next-generation therapeutics.
Kari Watson @macbiokari
744 Followers 1K Following Managing Partner & Co-founder at @macdougallbio. Life science PR and IR. Mom. @WilliamsCollege Eph. Avid golfer, hiker and snowboarder. Opinions are my own.
Beth from WMC @LifeScienceLove
510 Followers 966 Following I run WMC, a B2B life sciences marcom & PR consultancy. I’m obsessed w/ brand structure & culture. I tweet about stuff & things I love in the industry & beyond.
Xtalks Webinars @Xtalks
27K Followers 17K Following Provides insight on Life Science issues (#Pharma, #Biotech, #MedicalDevice) via breaking news & interactive webinars with industry experts
Khang🍸 @SoundVU
312 Followers 256 Following Scientist, drug dev #biotech • past cofounder @showdowngg • commentary on healthcare/finance/politics
Erin Simonds @ErinSimonds
71 Followers 170 Following Biotech, immunology, cancer research, nerd stuff. Recovering academic.👨🏻🔬 he/him.
Omid Veiseh @veiseho
3K Followers 3K Following Prof. @rice_bioe, @RiceUniversity and Co-founder @sigilon_inc and @AvengeBio | Bioengineer, Educator, Inventor, and Entrepreneur #veisehlab #immunoengineering
Ben Porter @bc_porter
719 Followers 972 Following Programme Manager working in #health #technology #innovation Interests: athletics, cake, CrossFit, health innovation & horizon scanning 🏳🌈🇬🇧
Stephen J. Ubl @steveubl
22K Followers 1K Following Proud to stand with the millions of Americans working to cure diseases. CEO of @PhRMA. Dad, husband & avid fan of @Twins & @Vikings.
BioPharma Dive @BioPharmaDive
13K Followers 320 Following We provide in-depth insight into the most significant news and trends shaping biotech and pharma. Sign up here: https://t.co/sTgs1kxwYE
Industry Dive @industrydive
4K Followers 278 Following Business journalism company that serves 14 million decision-makers across 32 publications - part of @InformaTechHQ
Cristina Rexach @rexach_cristina
61 Followers 59 Following AI | ChatGPT | Business Strategy | Process Improvement - Founder THINK LEAN & Director of Ops & Tech @digitalrecruiter
Dan Mendelson @dnmendelson
2K Followers 393 Following Leads healthcare innovation @JPMorgan. Founder and former CEO of @AvalereHealth. Passionate about improving employer-sponsored healthcare. Tweets are my own.
Morgan Health @MorganHealth
388 Followers 463 Following Morgan Health is a JPMorgan Chase business unit focused on improving the quality, equity and affordability of employer-sponsored health care.
Michelle Detwiler @dipp
2K Followers 561 Following @Biosprings: Growth stage investing in healthcare tech | https://t.co/GtkxDnA99v
Xiao Huang 黄潇 @XiaoHuangNano
498 Followers 490 Following Bioengineer working at the interface of immunology and nanomaterials, Asst Prof. @Drexel, Postdoc @UCSF, PhD @UCSB
U.S. CBO @USCBO
37K Followers 1 Following Congressional Budget Office Nonpartisan analysis for the U.S. Congress. For cost estimates, follow @USCBOCostEst.
PureTech @PureTechH
4K Followers 1K Following We're a biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases #Nasdaq #FTSE250
Daniel Blanco-Melo @DBM003
2K Followers 425 Following Studying past, present, and potentially future host-viral interactions 👨🏻💻👨🏻🔬🦠 #loveVirology #LatinxInSTEM 🇲🇽 | Assistant professor @FredHutch
University of Oxford @UniofOxford
1.0M Followers 2K Following Welcome to our official account 👋 Follow for the latest news, research and updates about life at Oxford.
The Business Magazine.. @BizInnovateMag
5K Followers 5K Following The South West region's leading independent B2B publication and event company. In print, online & in person. Formerly Business & Innovation Magazine
The Pharma Letter @ThePharmaLetter
24K Followers 2K Following Breaking news and analysis for the global pharmaceutical and biotechnology industries
BioWorld @BioWorld
39K Followers 9K Following Biopharma’s trusted news source. Lynn Yoffee, Jennifer Boggs, Karen Carey, Anette Breindl, Lee Landenberger, Randy Osborne, Mari Serebrov, Caroline Richards
Duke University Schoo.. @DukeMedSchool
14K Followers 791 Following One of the nation's leading institutions for health professions education, clinical care, biomedical research, and community partnership.
Trophic Communication.. @TrophicComms
222 Followers 303 Following Strategy & #communications consulting agency supporting public & investor relations needs for #lifescience companies globally
Connie L. Luthy @MPDexpert
1K Followers 5K Following translate research into life-changing Global manufactured Medical Products - drugs, devices, biotech, combination; anything requiring FDA approval #MedProdDev
Financial Times @FinancialTimes
7.5M Followers 1K Following This account is now closed. For the best of FT journalism, including breaking news and analysis, follow @ft
FierceBiotech @FierceBiotech
101K Followers 649 Following The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
Melanie Senior @RealEndptsMel
767 Followers 63 Following Biopharma writer (Nature Bio, IN VIVO, EY Life Sci.); runner & twitter schizo
Clive Cookson @clivecookson
6K Followers 305 Following Science Editor, Financial Times. All views are mine or borrowed from other people — and not necessarily the FT's.Important editorial by my colleague @steveusdin1 . What the numbers really say - and don't say - about Accelerated Approval. (Spoiler alert: it's NOT correct to say half of the drugs approved this way in cancer are ineffective). Via @BioCentury
Drive-by analysis of accelerated approval is intellectual malpractice. Medical journals and news publications have incorrectly concluded that half of cancer accelerated approvals are useless. BioCentury's @steveusdin1 explains why. buff.ly/4d123NU
A fantastic day celebrating 20 years of @Anglonordic Life Science Conference! BIG thank you to our brilliant chairs that hosted insightful #biotech and #technology company presentations, as well as panel sessions comprised of experts & industry leaders discussing the current…
Following the #publication of our #obesity research last month, NodThera features in a new piece in @BioCentury, which explores the potential of #NLRP3 inhibitors to enhance CV benefits. For more: biocentury.com/article/651740… #ICYMI #Pharma
Iovance Biotherapeutics was originally founded in 2007 & began as Genesis Biopharma in Nevada. They merged with Lion Biotechnologies in '13 & changed their name/rebranded as Iovance in '17. $IOVA. FDA approval today:
San Carlos, CA-based Iovance received FDA accelerated approval for TIL therapy lifileucel for relapsed metastatic melanoma & is 1st FDA-approved T cell therapy for a solid tumor cancer nbcnews.com/health/health-… & $IOVA approved as 1st treatment option for advanced melanoma after…
The approval of TILs has been one of the longest to arrive in immuno-oncology. TILs work, naturally in your body every day. Truly a case where the ‘process is the therapy’ cliche is true. Congrats to Iovance.
Breaking: House GOP rescinds endorsement of Donald Trump
🚨 A man who can't even be held responsible for mishandling classified information properly has absolutely no business occupying the Oval Office.🚨
@BioCentury Happy new year BioCentury! Thank you for your reporting & analysis.
Trying to get into #AI panel at #Jefferies23
All set for @BioCentury @BIA_UK event on sidelines of #Jefferies23 in London -> Planning for the Biotech Breakout. Doors open at 5pm. Hope to see you there! BioCenturyJefferies.com
💡 The @BIA_UK & @BioCentury are hosting an evening of C-level networking, discussion and planning for 2024 on the sidelines of the Jefferies London Healthcare conference on 14 November 2023 at @devereofficial #London 💫 Limited space is available ⭐ ow.ly/RcSJ50Q5ZA6
Expect pharma to take more upstream risk, says Jefferies’ Bar-Nahum. Ahead of the @Jefferies Healthcare conference in London, I talked w Gil Bar-Nahum about: when the market will thaw, what to expect in M&A, and what R&D areas to watch. @BioCentury. biocentury.com/article/650430…
The #BioCenturyChinaSummit kicks off soon! On-site registration opens 8AM on Nov. 2 at The St. Regis Shanghai Jingan, or register now: ow.ly/wekG50Q3cWr Can't make it to Shanghai? Access the sessions and networking opportunities from anywhere with a digital pass!
Fiona MacLaughlin of @JNJInnovation joins all-star line-up of speakers during Planning for the Biotech Breakout, hosted by BioCentury & @BIA_UK. Listen in as @FishburnSimone previews what to expect. Limited seats, register now: BioCenturyJefferies.com #biotech #investors
BioCentury's latest podcast: Merck’s $4.1B ADC deal with Daiichi. Roche's $7.1B Telavant TL1A takeout. And a deep dive into the emerging base editor toolkit buff.ly/3SfnHGj
Tough times require tough love: Five industry experts debate what #biotech CEOs need to do to build value during the worst downturn in a generation, and discuss the lessons learned from recent tier jumpers. View on-demand: bit.ly/3rX2A0R @Oppenheimer
If you missed the @BioCentury @Oppenheimer webinar yesterday on creating high value #biotechs, a free recording is now available on our website. ☆ My favorite quote: "You need to have guts!" ☆ Followed by: "No one wants to give up the CEO post." BioCenturyBacktoSchool.com
Tough times require tough love: Five industry experts debate what #biotech CEOs need to do to build value during the worst downturn in a generation, and discuss the lessons learned from recent tier jumpers. View on-demand: bit.ly/3rX2A0R @Oppenheimer
They will explore questions such as: What are the keys to building sustainable high-value biotechs? What is required for biotechs to jump market cap tier? And what are the principal challenges faced by today’s CEOs? Register today: biocentury.com/events/webinar…
TOMORROW at 11am ET, our @ProtagonistCEO Dinesh V. Patel, PhD and other experienced thought leaders will discuss the key ingredients to creating high-value biotechs in a free webinar presented by @BioCentury and @Oppenheimer.
Seasoned journalist @StephenPHansen @BioCentury led the heavy hitters on the investment panel @eqtventures @novoholdings @SofinnovaVC @AXAIM_UK While we are ‘Navigating turbulent markets’, the investors offered some valuable insights. #healthcare #financing #diagnostics
Tune in next Thursday, October 19 to see Boundless Chief Financial Officer, Jami Rubin take part in @BioCentury and @Oppenheimer & Co.’s live webinar, to discuss keys to sustainable, high-value biotechs and beyond. Learn more and register: biocentury.com/events/webinar…
Trends for United States
You might like
